Comparative analysis and generation of a robust HIV-1 DNA quantification assay

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• The persistent latent reservoir (LR) of HIV-1 prevents a complete cure.
• Novel therapeutic strategies like "shock and kill" and therapeutic vaccination aim to eradicate the LR.
• Robust DNA quantification assays are essential for monitoring LR changes in clinical trials, but no standard assay currently exists.

Purpose of the Study:

• To compare two distinct HIV-1 DNA quantification assays targeting the long terminal repeat (LTR).
• To assess the correlation and interchangeability of these assays, particularly in low viral copy scenarios.
• To evaluate assay performance in patient samples and improve quantification capacity through primer optimization.

Main Methods:

• Analysis of two HIV-1 quantification assays utilizing pre-amplification and LTR-targeting primers.
• Correlation analysis of assay results, including assessment in low copy number samples.
• Performance comparison between the RvS and CV assays in quantifying HIV-1 DNA in patient CD4+ T lymphocytes.
• In silico analysis of primer specificity and optimization using updated sequence data.

Main Results:

• A strong correlation (r=0.9759, P<0.0001) was observed between the two assays, maintained in low copy samples (r=0.8220, P<0.0001).
• The RvS assay demonstrated significantly better performance (P=0.0021) than the CV assay for HIV-1 total DNA quantification in patient samples.
• In silico analysis identified viral diversity as a potential limitation, but primer optimization led to a more broadly specific assay with enhanced quantification capacity (p=0.0057, n=17).

Conclusions:

• The analyzed LTR-targeting assays show high correlation and may be used interchangeably for HIV-1 DNA quantification.
• Assay optimization, particularly through improved primer design, can enhance specificity and capacity for detecting HIV-1 DNA in patient samples.
• These findings contribute to establishing reliable methods for monitoring the latent reservoir in HIV-1 cure research.